Sign in
4

Changes in Ownership

IDEXX LABORATORIES INC /DE Filed Acc 0001567619-22-019388

President & CEO sold 13,230 shares at an average $382.49 ($5,060,319)

  • President & CEO acquired 24,002 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

MAZELSKY JONATHAN JAY · President & CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2022-11-07 Exercise or conversion : show line 1 in the form +24,002 $52.00 $1,248,104 75,536.64 D
2022-11-07 Sale : show line 2 in the form −900 $378.60 $340,736 74,636.64 D
2022-11-07 Sale : show line 3 in the form −2,000 $379.50 $758,999 72,636.64 D
2022-11-07 Sale : show line 4 in the form −500 $380.85 $190,426 72,136.64 D
2022-11-07 Sale : show line 5 in the form −3,704 $382.81 $1,417,912 68,432.64 D
2022-11-07 Sale : show line 6 in the form −2,716 $383.29 $1,041,006 65,716.64 D
2022-11-07 Sale : show line 7 in the form −3,018 $384.47 $1,160,316 62,698.64 D
2022-11-07 Sale : show line 8 in the form −392 $385.01 $150,925 62,306.64 D
Open-market sales · 13,230 sh · avg $382.49 · $5,060,319

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-11-07 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right-to-buy) −24,002 $52.00 2023-12-04 24,002 0 D
Loading xslF345X03/doc1.xml…